We did not record any variations of inflammatory markers after 3 months of amlodipine monotherapy.
However, the variation of peripheral inflammatory mediators and the association with pulmonary histopathologic phenotypes remains a largely uninvestigated research area.
To our knowledge, no study has explored the variation of serum inflammatory markers in association with CT indices of emphysema and airway disease.
The predictive strength was calculated for single measurements and for the variation of each inflammatory marker.
This patient group shows a variation of age, inflammatory level and Larsen score.
Potential variation of the inflammatory markers by sex and age were assessed by the Wilcoxon rank-sum test and the Spearman rank correlation coefficient, respectively, within the group of neoplasm-free participants.
Intra and inter-assay coefficients of variation for inflammatory markers were respectively: 10% and 15% for IL-6; 16% and 15% for TNF-α; and 8 % and 5 for CRP.
In order to understand these copy number variation in the context of inflammatory breast cancer, we profiled the copy number variation observed in inflammatory breast cancer tissue (Fig. 10d).
The findings of the current study suggest a role of variation at inflammatory and matrix degrading genes with severity of lumbar disc degeneration, pain and disability.
This study suggests a role of variation at inflammatory and matrix degrading genes in severity of LDD and pain and disability outcome.
